STERIS plc Research and Development Expense
STERIS plc (STE) reported Research and Development Expense of $28.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- STERIS plc research and development expense for the quarter ending 2026-06-30 was $28.60M, a 8.33% increase year-over-year.
- STERIS plc research and development expense for the quarter ending 2026-03-31 was $28.80M, a 4.35% increase year-over-year.
- STERIS plc research and development expense for the quarter ending 2025-12-31 was $29.50M, a 7.66% increase year-over-year.
- STERIS plc research and development expense for the quarter ending 2025-09-30 was $28.20M, a 4.44% increase year-over-year.
- STERIS plc research and development expense for fiscal 2026 was $112.90M, a 4.93% increase from fiscal 2025.
- STERIS plc research and development expense for fiscal 2025 was $107.60M, a 3.76% increase from fiscal 2024.
- STERIS plc research and development expense for fiscal 2024 was $103.70M, a 5.30% increase from fiscal 2023.
- STERIS plc research and development expense for fiscal 2023 was $98.48M, a 13.63% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.60M 10-Q · filed 2026-08-07 | $57.40M derived: sum of 2 quarters · filed 2026-08-07 | $86.90M derived: sum of 3 quarters · filed 2026-08-07 | $115.10M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $28.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $58.30M derived: sum of 2 quarters · filed 2026-05-29 | $86.50M derived: sum of 3 quarters · filed 2026-05-29 | $112.90M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $29.50M 10-Q · filed 2026-02-06 | $57.70M derived: sum of 2 quarters · filed 2026-02-06 | $84.10M 10-Q · filed 2026-02-06 | $111.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $28.20M 10-Q · filed 2025-11-06 | $54.60M 10-Q · filed 2025-11-06 | $82.20M derived: sum of 3 quarters · filed 2026-08-07 | $109.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $26.40M 10-Q · filed 2026-08-07 | $54.00M derived: sum of 2 quarters · filed 2026-08-07 | $81.40M derived: sum of 3 quarters · filed 2026-08-07 | $108.40M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $27.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $55.00M derived: sum of 2 quarters · filed 2026-05-29 | $82.00M derived: sum of 3 quarters · filed 2026-05-29 | $107.60M 10-K · filed 2026-05-29 | $107.65M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $27.40M 10-Q · filed 2026-02-06 | $27.36M 10-Q · filed 2025-02-07 | $54.40M derived: sum of 2 quarters · filed 2026-02-06 | $80.00M 10-Q · filed 2026-02-06 | $79.96M 10-Q · filed 2025-02-07 | $107.48M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $27.00M 10-Q · filed 2025-11-06 | $27.03M 10-Q · filed 2024-11-07 | $52.60M 10-Q · filed 2025-11-06 | $52.60M 10-Q · filed 2024-11-07 | $80.08M derived: sum of 3 quarters · filed 2026-05-29 | $105.34M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $25.60M 10-Q · filed 2025-08-07 | $25.57M 10-Q · filed 2024-08-08 | $53.08M derived: sum of 2 quarters · filed 2026-05-29 | $78.34M derived: sum of 3 quarters · filed 2026-05-29 | $104.61M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $27.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $52.74M derived: sum of 2 quarters · filed 2026-05-29 | $79.01M derived: sum of 3 quarters · filed 2026-05-29 | $103.70M 10-K · filed 2026-05-29 | $103.68M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $25.25M 10-Q · filed 2025-02-07 | $25.91M 10-Q · filed 2024-02-08 | $51.52M derived: sum of 2 quarters · filed 2025-02-07 | $76.22M 10-Q · filed 2025-02-07 | $78.46M 10-Q · filed 2024-02-08 | $99.50M derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-09-30 | $26.27M 10-Q · filed 2024-11-07 | $27.04M 10-Q · filed 2023-11-07 | $50.96M 10-Q · filed 2024-11-07 | $52.55M 10-Q · filed 2023-11-07 | $74.25M derived: sum of 3 quarters · filed 2025-05-29 | $99.76M derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-06-30 | $24.69M 10-Q · filed 2024-08-08 | $25.50M 10-Q · filed 2023-08-08 | $47.98M derived: sum of 2 quarters · filed 2025-05-29 | $73.49M derived: sum of 3 quarters · filed 2025-05-29 | $98.42M derived: sum of 4 quarters · filed 2025-05-29 | |||
| 2023-03-31 | $23.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $48.80M derived: sum of 2 quarters · filed 2025-05-29 | $73.73M derived: sum of 3 quarters · filed 2025-05-29 | $98.48M 10-K · filed 2025-05-29 | $101.58M 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $25.51M 10-Q · filed 2024-02-08 | $50.44M derived: sum of 2 quarters · filed 2024-02-08 | $75.19M 10-Q · filed 2024-02-08 | $100.01M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $24.93M 10-Q · filed 2023-11-07 | $49.68M 10-Q · filed 2023-11-07 | $74.50M derived: sum of 3 quarters · filed 2024-05-29 | $99.32M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $24.75M 10-Q · filed 2023-08-08 | $49.57M derived: sum of 2 quarters · filed 2024-05-29 | $74.39M derived: sum of 3 quarters · filed 2024-05-29 | $93.22M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $24.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $49.64M derived: sum of 2 quarters · filed 2024-05-29 | $68.47M derived: sum of 3 quarters · filed 2024-05-29 | $86.66M 10-K · filed 2024-05-29 | $87.94M 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $24.82M 10-Q · filed 2023-02-08 | $43.66M derived: sum of 2 quarters · filed 2023-02-08 | $61.85M 10-Q · filed 2023-02-08 | $79.36M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $18.83M 10-Q · filed 2022-11-09 | $37.02M 10-Q · filed 2022-11-09 | $54.54M derived: sum of 3 quarters · filed 2023-05-26 | $70.98M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $18.19M 10-Q · filed 2022-08-08 | $35.71M derived: sum of 2 quarters · filed 2023-05-26 | $52.14M derived: sum of 3 quarters · filed 2023-05-26 | $68.29M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $17.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $33.95M derived: sum of 2 quarters · filed 2023-05-26 | $50.09M derived: sum of 3 quarters · filed 2023-05-26 | $66.33M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $16.44M 10-Q · filed 2022-02-09 | $32.58M derived: sum of 2 quarters · filed 2022-02-09 | $48.81M 10-Q · filed 2022-02-09 | $66.04M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $16.14M 10-Q · filed 2021-11-08 | $32.37M 10-Q · filed 2021-11-08 | $49.60M derived: sum of 3 quarters · filed 2022-05-31 | $66.09M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $16.23M 10-Q · filed 2021-08-09 | $33.46M derived: sum of 2 quarters · filed 2022-05-31 | $49.94M derived: sum of 3 quarters · filed 2022-05-31 | $66.19M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $17.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $33.71M derived: sum of 2 quarters · filed 2022-05-31 | $49.96M derived: sum of 3 quarters · filed 2022-05-31 | $65.55M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $16.49M 10-Q · filed 2021-02-09 | $32.74M derived: sum of 2 quarters · filed 2021-02-09 | $48.32M 10-Q · filed 2021-02-09 | $64.20M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $16.25M 10-Q · filed 2020-11-06 | $31.83M 10-Q · filed 2020-11-06 | $47.71M derived: sum of 3 quarters · filed 2021-05-28 | $62.88M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $15.59M 10-Q · filed 2020-08-07 | $31.46M derived: sum of 2 quarters · filed 2021-05-28 | $46.63M derived: sum of 3 quarters · filed 2021-05-28 | $62.40M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $31.05M derived: sum of 2 quarters · filed 2021-05-28 | $46.82M derived: sum of 3 quarters · filed 2021-05-28 | $63.04M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $15.17M 10-Q · filed 2020-02-10 | $30.94M derived: sum of 2 quarters · filed 2020-02-10 | $47.16M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $15.77M 10-Q · filed 2019-11-07 | $31.99M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $16.22M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $60.78M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $59.40M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |